Verapamil inhibits calcification and matrix vesicle activity of bovine vascular smooth muscle cells

Xuening (Neal) Chen, Fatih Kircelli, Kalisha D. O'Neill, Xianming Chen, Sharon Moe

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Calcium channel activity in vascular smooth muscle cells is a critical component during vascular calcification and formation of matrix vesicles. Here, we examined whether the blockade of L-type calcium channels inhibits these functions. Bovine vascular smooth muscle cells or rat aorta organ cultures were incubated in media known to promote calcification and treated with the L-type calcium channel inhibitors verapamil, nifedipine, or nimodipine. The phenylalkylamine, verapamil, significantly decreased calcification of the vascular smooth muscle cells and rat aorta, in a dose-dependent manner, whereas the dihydropyridines, nifedipine and nimodipine, had no effect. Furthermore, verapamil, but not nifedipine, significantly decreased the alkaline phosphatase activity of bovine vascular smooth muscle cells. Verapamil pretreatment of the cells also inhibited matrix vesicle alkaline phosphatase activity and reduced the ability of these matrix vesicles to subsequently calcify on a type I collagen extracellular matrix scaffold. As L-type channels are blocked by verapamil and dihydropyridines, we suggest that verapamil inhibits vascular smooth muscle mineralization and matrix vesicle activity by mechanisms other than the simple blockade of this calcium channel activity.

Original languageEnglish
Pages (from-to)436-442
Number of pages7
JournalKidney International
Volume77
Issue number5
DOIs
StatePublished - Mar 2010

Fingerprint

Verapamil
Vascular Smooth Muscle
Smooth Muscle Myocytes
Nifedipine
Dihydropyridines
L-Type Calcium Channels
Nimodipine
Calcium Channels
Alkaline Phosphatase
Aorta
Vascular Calcification
Organ Culture Techniques
Collagen Type I
Extracellular Matrix

Keywords

  • Calcium
  • Cell signaling
  • Mineral metabolism
  • Vascular calcification

ASJC Scopus subject areas

  • Nephrology

Cite this

Verapamil inhibits calcification and matrix vesicle activity of bovine vascular smooth muscle cells. / Chen, Xuening (Neal); Kircelli, Fatih; O'Neill, Kalisha D.; Chen, Xianming; Moe, Sharon.

In: Kidney International, Vol. 77, No. 5, 03.2010, p. 436-442.

Research output: Contribution to journalArticle

Chen, Xuening (Neal) ; Kircelli, Fatih ; O'Neill, Kalisha D. ; Chen, Xianming ; Moe, Sharon. / Verapamil inhibits calcification and matrix vesicle activity of bovine vascular smooth muscle cells. In: Kidney International. 2010 ; Vol. 77, No. 5. pp. 436-442.
@article{a9fd071dd1a5410ea2d770b3dcf1975e,
title = "Verapamil inhibits calcification and matrix vesicle activity of bovine vascular smooth muscle cells",
abstract = "Calcium channel activity in vascular smooth muscle cells is a critical component during vascular calcification and formation of matrix vesicles. Here, we examined whether the blockade of L-type calcium channels inhibits these functions. Bovine vascular smooth muscle cells or rat aorta organ cultures were incubated in media known to promote calcification and treated with the L-type calcium channel inhibitors verapamil, nifedipine, or nimodipine. The phenylalkylamine, verapamil, significantly decreased calcification of the vascular smooth muscle cells and rat aorta, in a dose-dependent manner, whereas the dihydropyridines, nifedipine and nimodipine, had no effect. Furthermore, verapamil, but not nifedipine, significantly decreased the alkaline phosphatase activity of bovine vascular smooth muscle cells. Verapamil pretreatment of the cells also inhibited matrix vesicle alkaline phosphatase activity and reduced the ability of these matrix vesicles to subsequently calcify on a type I collagen extracellular matrix scaffold. As L-type channels are blocked by verapamil and dihydropyridines, we suggest that verapamil inhibits vascular smooth muscle mineralization and matrix vesicle activity by mechanisms other than the simple blockade of this calcium channel activity.",
keywords = "Calcium, Cell signaling, Mineral metabolism, Vascular calcification",
author = "Chen, {Xuening (Neal)} and Fatih Kircelli and O'Neill, {Kalisha D.} and Xianming Chen and Sharon Moe",
year = "2010",
month = "3",
doi = "10.1038/ki.2009.481",
language = "English",
volume = "77",
pages = "436--442",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Verapamil inhibits calcification and matrix vesicle activity of bovine vascular smooth muscle cells

AU - Chen, Xuening (Neal)

AU - Kircelli, Fatih

AU - O'Neill, Kalisha D.

AU - Chen, Xianming

AU - Moe, Sharon

PY - 2010/3

Y1 - 2010/3

N2 - Calcium channel activity in vascular smooth muscle cells is a critical component during vascular calcification and formation of matrix vesicles. Here, we examined whether the blockade of L-type calcium channels inhibits these functions. Bovine vascular smooth muscle cells or rat aorta organ cultures were incubated in media known to promote calcification and treated with the L-type calcium channel inhibitors verapamil, nifedipine, or nimodipine. The phenylalkylamine, verapamil, significantly decreased calcification of the vascular smooth muscle cells and rat aorta, in a dose-dependent manner, whereas the dihydropyridines, nifedipine and nimodipine, had no effect. Furthermore, verapamil, but not nifedipine, significantly decreased the alkaline phosphatase activity of bovine vascular smooth muscle cells. Verapamil pretreatment of the cells also inhibited matrix vesicle alkaline phosphatase activity and reduced the ability of these matrix vesicles to subsequently calcify on a type I collagen extracellular matrix scaffold. As L-type channels are blocked by verapamil and dihydropyridines, we suggest that verapamil inhibits vascular smooth muscle mineralization and matrix vesicle activity by mechanisms other than the simple blockade of this calcium channel activity.

AB - Calcium channel activity in vascular smooth muscle cells is a critical component during vascular calcification and formation of matrix vesicles. Here, we examined whether the blockade of L-type calcium channels inhibits these functions. Bovine vascular smooth muscle cells or rat aorta organ cultures were incubated in media known to promote calcification and treated with the L-type calcium channel inhibitors verapamil, nifedipine, or nimodipine. The phenylalkylamine, verapamil, significantly decreased calcification of the vascular smooth muscle cells and rat aorta, in a dose-dependent manner, whereas the dihydropyridines, nifedipine and nimodipine, had no effect. Furthermore, verapamil, but not nifedipine, significantly decreased the alkaline phosphatase activity of bovine vascular smooth muscle cells. Verapamil pretreatment of the cells also inhibited matrix vesicle alkaline phosphatase activity and reduced the ability of these matrix vesicles to subsequently calcify on a type I collagen extracellular matrix scaffold. As L-type channels are blocked by verapamil and dihydropyridines, we suggest that verapamil inhibits vascular smooth muscle mineralization and matrix vesicle activity by mechanisms other than the simple blockade of this calcium channel activity.

KW - Calcium

KW - Cell signaling

KW - Mineral metabolism

KW - Vascular calcification

UR - http://www.scopus.com/inward/record.url?scp=76749098069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76749098069&partnerID=8YFLogxK

U2 - 10.1038/ki.2009.481

DO - 10.1038/ki.2009.481

M3 - Article

C2 - 20016465

AN - SCOPUS:76749098069

VL - 77

SP - 436

EP - 442

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 5

ER -